Related Experiment Video
Updated: Jun 1, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Angiotensin II-mediated Nrf2 down-regulation: a potential causing factor for renal fibrosis?
1BK21 Project Team, College of Pharmacy, Chosun University, Gwangju 501-759, Republic of Korea. kwkang@chosun.ac.kr
Abstract:
Epithelial-mesenchymal transition (EMT), a phenotype conversion of epithelial cells to myofibroblasts, is closely related with pathogenesis of renal fibrosis. Although it has been known that angiotensin II (ATII) stimulates EMT process in various cell types, the precise molecular mechanisms had not been clearly demonstrated. In this issue, Kang et al. show that AII suppresses NF-E2-related factor 2 (Nrf2) signaling and enhances transforming growth factor-β1's activity to induce EMT in renal epithelial cells (Kang et al., 2011). They suggest that ATII-mediated EMT stimulating effect may result from the increased oxidative stress via defect in Nrf2-antioxidant system. This report proposes a possible mechanism of ATII-mediated renal fibrosis.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Acute Kidney Injury II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hypertension II: Pathophysiology
Heart Failure II: Pathophysiology
